Literature DB >> 29971647

Biomarkers and Pharmacogenomics in Kidney Transplantation.

L E Crowley1, M Mekki2, S Chand3.   

Abstract

This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29971647     DOI： 10.1007/s40291-018-0349-5

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


  123 in total

Review 1.  Molecular markers of rejection and tolerance: lessons from clinical research.

Authors:  Ondrej Viklicky; Petra Hribova; Irena Brabcova
Journal:  Nephrol Dial Transplant       Date:  2013-06-05       Impact factor: 5.992

2.  Serum neutrophil gelatinase-associated lipocalin and interleukin-18 as predictive biomarkers for delayed graft function after kidney transplantation.

Authors:  Eun Young Lee; Myoung Soo Kim; Yongjung Park; Hyon-Suk Kim
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  Proteins in Preservation Fluid as Predictors of Delayed Graft Function in Kidneys from Donors after Circulatory Death.

Authors:  Bas W M van Balkom; Hendrik Gremmels; Liselotte S S Ooms; Raechel J Toorop; Frank J M F Dor; Olivier G de Jong; Laura A Michielsen; Gert J de Borst; Wilco de Jager; Alferso C Abrahams; Arjan D van Zuilen; Marianne C Verhaar
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-08       Impact factor: 8.237

4.  A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

Authors:  F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen
Journal:  Am J Transplant       Date:  2010-03       Impact factor: 8.086

5.  Urine proteomics to detect biomarkers for chronic allograft dysfunction.

Authors:  Luís F Quintana; Amanda Solé-Gonzalez; Susana G Kalko; Elisenda Bañon-Maneus; Manel Solé; Fritz Diekmann; Alex Gutierrez-Dalmau; Joaquin Abian; Josep M Campistol
Journal:  J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 10.121

Review 6.  RNA-Seq: a revolutionary tool for transcriptomics.

Authors:  Zhong Wang; Mark Gerstein; Michael Snyder
Journal:  Nat Rev Genet       Date:  2009-01       Impact factor: 53.242

7.  TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.

Authors:  J-Y Park; M H Park; H Park; J Ha; S J Kim; C Ahn
Journal:  Tissue Antigens       Date:  2004-12

8.  Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.

Authors:  Bärbel Breulmann; Christos Bantis; Magdalena Siekierka; Cornelia Blume; Sendogan Aker; Nicola Kuhr; Bernd Grabensee; Katrin Ivens
Journal:  Clin Transplant       Date:  2007 Sep-Oct       Impact factor: 2.863

9.  Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study.

Authors:  Maria E Hollmen; Lauri E Kyllönen; Kaija A Inkinen; Martti L T Lalla; Jussi Merenmies; Kaija T Salmela
Journal:  Crit Care       Date:  2011-05-05       Impact factor: 9.097

10.  Global pharmacogenomics: distribution of CYP3A5 polymorphisms and phenotypes in the Brazilian population.

Authors:  Guilherme Suarez-Kurtz; Daniela D Vargens; Ana Beatriz Santoro; Mara H Hutz; Maria Elisabete de Moraes; Sérgio D J Pena; Ândrea Ribeiro-dos-Santos; Marco A Romano-Silva; Claudio José Struchiner
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.